Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: dabrafenib
DRUG: trametinib

Sponsor

Novartis Pharmaceuticals